Peer B. Jacobson

3.9k total citations
51 papers, 2.2k citations indexed

About

Peer B. Jacobson is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Immunology. According to data from OpenAlex, Peer B. Jacobson has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Genetics and 10 papers in Immunology. Recurrent topics in Peer B. Jacobson's work include Hormonal Regulation and Hypertension (16 papers), Estrogen and related hormone effects (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Peer B. Jacobson is often cited by papers focused on Hormonal Regulation and Hypertension (16 papers), Estrogen and related hormone effects (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Peer B. Jacobson collaborates with scholars based in United States, United Kingdom and Germany. Peer B. Jacobson's co-authors include Robert S. Jacobs, Denis J. Schrier, Stephen Lund, Henry W. Weisman, Rosa Marotta, Meredith M. Platt, William Breitbart, Kathy Corbera, Curtis M. Tyree and Michael J. Coghlan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Peer B. Jacobson

51 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peer B. Jacobson United States	26	529	374	296	291	288	51	2.2k
Su Yuan China	27	1.0k 1.9×	135 0.4×	214 0.7×	145 0.5×	694 2.4×	93	2.5k
Sabera Ruždijić Serbia	26	837 1.6×	50 0.1×	52 0.2×	224 0.8×	236 0.8×	93	1.8k
Ian W. Rodger United Kingdom	28	1.1k 2.0×	51 0.1×	685 2.3×	40 0.1×	949 3.3×	104	2.9k
Giampiero Bricca France	27	1.0k 2.0×	287 0.8×	154 0.5×	36 0.1×	205 0.7×	105	2.5k
Pierre Rivière France	31	731 1.4×	170 0.5×	58 0.2×	26 0.1×	556 1.9×	76	2.1k
D. R. Waud United States	22	1.0k 1.9×	68 0.2×	137 0.5×	98 0.3×	310 1.1×	64	2.4k
David P. Brooks United States	36	1.4k 2.6×	579 1.5×	135 0.5×	27 0.1×	819 2.8×	178	4.0k
Yiying Zhang United States	21	737 1.4×	228 0.6×	80 0.3×	135 0.5×	1.5k 5.2×	41	3.6k
Albert L. Hyman United States	37	1.1k 2.1×	312 0.8×	492 1.7×	102 0.4×	1.6k 5.5×	195	4.4k
Stephanie J. Murphy United States	31	656 1.2×	545 1.5×	67 0.2×	108 0.4×	198 0.7×	77	2.9k

Countries citing papers authored by Peer B. Jacobson

Since Specialization

Citations

This map shows the geographic impact of Peer B. Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peer B. Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peer B. Jacobson more than expected).

Fields of papers citing papers by Peer B. Jacobson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peer B. Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peer B. Jacobson. The network helps show where Peer B. Jacobson may publish in the future.

Co-authorship network of co-authors of Peer B. Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Peer B. Jacobson. A scholar is included among the top collaborators of Peer B. Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peer B. Jacobson. Peer B. Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mothe, Andrea J., Peer B. Jacobson, Antigona Ulndreaj, et al.. (2022). Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury. Neurobiology of Disease. 172. 105812–105812. 16 indexed citations

Mothe, Andrea J., Lili Huang, Philippe P. Monnier, et al.. (2020). Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats. Neurobiology of Disease. 143. 104995–104995. 31 indexed citations

Barsegyan, Areg, Piray Atsak, Wilfried Hornberger, et al.. (2015). The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition Memory. Neuropsychopharmacology. 40(8). 1979–1989. 19 indexed citations

Katz, David A., C. Locke, Peer B. Jacobson, et al.. (2013). Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384. Translational Psychiatry. 3(8). e295–e295. 12 indexed citations

Malek, Sarah, Susannah J. Sample, Brett Nemke, et al.. (2012). Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Veterinary Research. 8(1). 185–185. 83 indexed citations

Mohler, Eric G., Kaitlin E. Browman, Stella Markosyan, et al.. (2011). Acute Inhibition of 11β-Hydroxysteroid Dehydrogenase Type-1 Improves Memory in Rodent Models of Cognition. Journal of Neuroscience. 31(14). 5406–5413. 39 indexed citations

Yang, Ruojing, Denise M. Wilcox, Deanna L. Haasch, et al.. (2007). Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor γ Coactivator 1β and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese Mice. Journal of Biological Chemistry. 282(31). 22765–22774. 51 indexed citations

Mayer, Alejandro M. S., Mary L. Hall, Michael J. Fay, et al.. (2007). Differential Effects of Domoic Acid and E. coli Lipopolysaccharide on Tumor Necrosis Factor-α, Transforming Growth Factor-β1 and Matrix Metalloproteinase-9 Release by Rat Neonatal Microglia: Evaluation of the Direct Activation Hypothesis. Marine Drugs. 5(3). 113–135. 5 indexed citations

Wilcox, Denise M., Ruojing Yang, Sherry J. Morgan, et al.. (2006). Delivery of RNAi reagents in murine models of obesity and diabetes.. Europe PMC (PubMed Central). 8 indexed citations

10.

Esbenshade, Timothy A., Arthur A. Hancock, Robert S. Bitner, et al.. (2006). Distinctions and contradistinctions between antiobesity histamine H3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists. Inflammation Research. 55(S1). S42–S44. 11 indexed citations

11.

Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5414–5419. 18 indexed citations

12.

Yeh, Vince S. C., Ravi Kurukulasuriya, David J. Madar, et al.. (2006). Synthesis and structural activity relationship of 11β-HSD1 inhibitors with novel adamantane replacements. Bioorganic & Medicinal Chemistry Letters. 16(20). 5408–5413. 23 indexed citations

13.

Sorensen, Bryan K., Jiahong Wang, Steven Fung, et al.. (2006). Adamantane 11-β-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction. Bioorganic & Medicinal Chemistry Letters. 16(23). 5958–5962. 30 indexed citations

14.

Hancock, Arthur A., Thomas A. Fey, Eugene N. Bush, et al.. (2005). Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy. Inflammation Research. 54(S1). S27–S29. 13 indexed citations

15.

Hancock, Arthur A., Youssef L. Bennani, Eugene N. Bush, et al.. (2004). Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. European Journal of Pharmacology. 487(1-3). 183–197. 79 indexed citations

16.

Hancock, Arthur A., et al.. (2004). Histamine H 3 antagonists in models of obesity. Inflammation Research. 53(0). S47–S48. 12 indexed citations

17.

Mayer, Alejandro M. S., Mary L. Hall, Michael J. Fay, et al.. (2001). Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia. BMC Pharmacology. 1(1). 7–7. 25 indexed citations

18.

Coghlan, Michael J., Philip R. Kym, Steven W. Elmore, et al.. (2001). Synthesis and Characterization of Non-Steroidal Ligands for the Glucocorticoid Receptor: Selective Quinoline Derivatives with Prednisolone-Equivalent Functional Activity. Journal of Medicinal Chemistry. 44(18). 2879–2885. 78 indexed citations

19.

Mayer, Alejandro M. S., Peer B. Jacobson, William Fenical, Robert S. Jacobs, & Keith B. Glaser. (1998). Pharmacological characterization of the pseudopterosins: Novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae. Life Sciences. 62(26). PL401–PL407. 87 indexed citations

20.

Jacobson, Peer B. & Robert S. Jacobs. (1992). Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: Physiological and biochemical studies in murine inflammatory models.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 866–873. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact